Clinical Trials Directory

Trials / Sponsors / Conjupro Biotherapeutics, Inc.

Conjupro Biotherapeutics, Inc.

Industry · 10 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
RecruitingPhase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Cancer, Solid Tumor Cancer, Advanced Metastatic Cancer
Phase 12026-03-03
RecruitingA Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Cancer, Cancer (Solid Tumors)
Phase 12025-12-02
WithdrawnNBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy
Breast Cancer, Peripheral Neuropathy
Phase 22023-06-30
RecruitingA Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Cancer, Cancer, Lung
Phase 12023-06-06
WithdrawnDose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Cancers
Pancreatic Cancer, Gastric Cancer
Phase 12022-11-16
TerminatedDose Escalation and Expansion Study of CPO107 for Patients With Advanced CD20-positive Non-Hodgkins Lymphoma
CD20 Positive Non Hodgkin Lymphoma
Phase 12021-12-13
WithdrawnSingle and Multiple Doses of HA115 and Food Effect in Healthy Adult Volunteers
Asthma
Phase 12021-10-01
TerminatedDose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Solid Tumor
Phase 12021-03-24
WithdrawnPLM60 for Peripheral T Cell Lymphoma (PTCL)
Peripheral T Cell Lymphoma
Phase 1 / Phase 22021-01-01
CompletedBioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy
Hypertension
Phase 12018-05-31